TELCON RF PHARMACEUTICAL. Inc. (KOSDAQ:200230)

South Korea flag South Korea · Delayed Price · Currency is KRW
846.00
+7.00 (0.83%)
Apr 3, 2026, 3:30 PM KST
Market Cap30.50B -32.9%
Revenue (ttm)43.16B +14.0%
Net Income-11.46B
EPS-239.00
Shares Out36.05M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume229,518
Average Volume448,437
Open840.00
Previous Close839.00
Day's Range835.00 - 860.00
52-Week Range685.00 - 4,433.33
Beta0.72
RSI52.70
Earnings DateApr 3, 2026

About TELCON RF PHARMACEUTICAL.

TELCON RF PHARMACEUTICAL. Inc. primarily engages in the development, production, and sale of RF coaxial connectors worldwide. It also provides coaxial couplers, distributors, and arresters, as well as cable assemblies; and pharmaceuticals. The company was formerly known as Telcon Co., Ltd. TELCON RF PHARMACEUTICAL. Inc. was founded in 1999 and is headquartered in Yongin-si, South Korea. [Read more]

Sector Technology
Founded 1999
Employees 126
Stock Exchange KOSDAQ
Ticker Symbol 200230
Full Company Profile

Financial Performance

In 2025, TELCON RF PHARMACEUTICAL.'s revenue was 43.16 billion, an increase of 13.99% compared to the previous year's 37.87 billion. Losses were -11.46 billion, -56.48% less than in 2024.

Financial Statements